HomeIKT • NASDAQ
add
Inhibikase Therapeutics Inc
Previous close
$1.51
Day range
$1.47 - $1.65
Year range
$1.42 - $4.20
Market cap
116.99M USD
Avg Volume
132.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.56M | 181.63% |
Net income | -9.92M | -99.93% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.81M | -114.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 87.67M | 1,004.10% |
Total assets | 88.85M | 906.63% |
Total liabilities | 8.80M | 135.90% |
Total equity | 80.05M | — |
Shares outstanding | 74.52M | — |
Price to book | 1.41 | — |
Return on assets | -29.57% | — |
Return on capital | -32.65% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.92M | -99.93% |
Cash from operations | -5.57M | -10.29% |
Cash from investing | 9.84M | 287.06% |
Cash from financing | 31.77K | -99.02% |
Net change in cash | 4.30M | 486.72% |
Free cash flow | -2.40M | 23.94% |
About
Founded
2008
Headquarters
Website
Employees
15
